The present study evaluated mechanical stretch-induced apoptosis in swine vascular smooth muscle cells (VSMC) of different phenotypes. We demonstrated that differentiated VSMC express a greater level of Bcl-2-associated death factor (BAD) and have a significant cell loss when exposed to mechanical stretch (10% elongation, 1 Hz) for 24 h. We further demonstrated that apoptosis was significantly increased only in differentiated VSMC exposed to mechanical stretch. To test the hypothesis that the intracellular level of BAD in VSMC determines its response to mechanical stretch-induced apoptosis, we examined whether BAD expression was upregulated by mechanical stretch-induced apoptosis and was associated with the increase in the apoptosis level of differentiated VSMC. When exposed to mechanical stretch, the expression of BAD in differentiated VSMC was elevated at 1 h and remained at higher levels during the application of stretch (24 h). In contrast, Bcl-2 expression was suppressed during the application of stretch. Moreover, the proapoptotic function of BAD was inhibited by overexpression of Bcl-2 through transient transfection of VSMC with pCEP4-Bcl-2 or incubation of VSMC with vascular epithelial growth factor. These results suggest that mechanical stretch-induced VSMC apoptosis is phenotype dependent. The higher levels of apoptosis of differentiated VSMC upon mechanical stretch were, at least in part, dependent on their intrinsic level of BAD.

Keywords:
Vascular smooth muscle cells, Differentiation, Mechanical stretch, Bcl-2-associated death factor, Apoptosis
1.
Motwani JG, Topol EJ: Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998;97:916–931.
2.
Pasterkamp G, de Kleijn DP, Borst C: Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: potential mechanisms and clinical implications. Cardiovasc Res 2000;45:843–852.
3.
Dorbrin PB, Littooy FN, Endean ED: Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery 1989;105:393–400.
4.
Shaw A, Xu Q: Biomechanical stress-induced signaling in smooth muscle cells: an update. Curr Vasc Pharmacol 2003;1:41–58.
5.
Wilson E, Mai Q, Sudhir K, Weiss RH, Ives HE: Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol 1993;123:741–747.
6.
Reusch P, Wagdy H, Reusch R, Wilson E, Ives HE: Mechanical strain increase smooth muscle and decrease nonmuscle myosin expression in rat vascular smooth muscle cells. Circ Res 1996;79:1046–1053.
7.
Wernig F, Mayr M, Xu Q: Mechanical stretch-induced apoptosis in smooth muscle cells is mediated by β1-integrin signaling pathways. Hypertension 2003;42:903–911.
8.
Schordan E, Welsch S, Rothhut S, Lambert A, Barthelmebs M, Helwig J, Massfelder T: Role of parathyroid hormone-related protein in the regulation of stretch-induced renal vascular smooth muscle cell proliferation. J Am Soc Nephrol 2004;15:3016–3025.
9.
Pollman MJ, Hall JL, Gibbons GH: Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury: influence of redox state and cell phenotype. Circ Res 1999;84:113–121.
10.
Libby P, O’Brien KV: Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol 1983;115:217–223.
11.
Hultgardh-Nilsson A, Krondahl U, Jiang WQ, Nilsson J, Ringertz AR: Endogenous activation of c-myc expression and DNA synthesis in serum-starved neonatal rat smooth muscle cells. Differentiation 1993;52:161–168.
12.
Lavie J, Dandre F, Louis H, Lamaziere JM, Bonnet J: Vascular cell adhesion molecule-I gene expression during human smooth muscle cell differentiation is independent of NF-kB activation. J Biol Chem 1999;274:2308–2314.
13.
Su BY, Mitra S, Gregg H, Flavahan S, Chotani MA, Clark KR, Goldschmidt PJ, Flavahan NS: Redox regulation of vascular smooth muscle cell differentiation. Circ Res 2001;89:39–46.
14.
Mayr M, Li C, Zou Y, Huemer U, Hu Y, Xu Q: Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J 2000;14:261–270.
15.
McDonnell TJ, Beham A, Sarkiss M, Anderson MM, Lo P: Importance of the Bcl-2 family in cell death regulation. Experientia 1996;52:1008–1017.
16.
Chao DT, Korsmeyer SJ: Bcl-2 family: regulators of cell death. Annu Rev Immunol 1998;16:395–419.
17.
Kirschenlohr HL, Metcalfe JC, Weissberg PL, Grainger DJ: Proliferating of human aortic vascular smooth muscle cells in culture is modulated by active TGF-β. Cardiovasc Res 1995;29:848–855.
18.
Sotoudeh M, Li YS, Yajima N, Chang CC, Tsou TC, Wang Y, Usami S, Patcliffe A, Chien S, Shyy JYJ: Induction of apoptosis in vascular smooth muscle cells by mechanical stretch. Am J Physiol Heart Circ Physiol 2002;282:H1709–H1716.
19.
Birukov KG, Shirinsky VP, Stepanova OV, Tkachuk VA, Hahn AW, Resink TJ, Smirnov VN: Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem 1995;144:131–139.
20.
Hubschmid U, Leong-Morgenthaler PM, Basset-Dardare A, Ruault S, Frey P: In vitro growth of human urinary tract smooth muscle cells on laminin and collagen type I-coated membrane under static and dynamic conditions. Tissue Eng 2005;11:161–171.
21.
Kitada S, Krajewska M, Zhang X, Scudiero D, Zapata JM, Wang HG, Shabaik A, Tudor G, Krajewski S, Myers TG, Johnson GS, Sausville EA, Reed JC: Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am J Pathol 1998;152:51–61.
22.
Nor JE, Christensen J, Mooney DJ, Polverini PJ: Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999;154:375–384.
23.
Dias S, Shmelkov SV, Lam G, Rafii S: VEGF165 promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood 2001;99:2532–2540.
24.
Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ: Serine phosporylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not Bcl-XL. Cell 1996;87:619–628.
25.
Zha J, Harada H, Osipov K, Jockel J, Waksman G, Korsmeyer SJ: BH-3 domain of BAD is required for heterodimerization with Bcl-XL and pro-apoptotic activity. J Biol Chem 1997;272:24101–24104.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.